Clinical Trial Results:
AN EXPLORATIVE PHASE IIa STUDY TO ASSESS SAFETY, TOLERABILITY,
PHARMACODYNAMICS AND PHARMACOKINETICS OF VAS203 IN PATIENTS WITH
MODERATE AND SEVERE TRAUMATIC BRAIN INJURY
Summary
|
|
EudraCT number |
2009-012338-56 |
Trial protocol |
GB FR ES AT |
Global completion date |
14 Sep 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
23 Mar 2022
|
First version publication date |
23 Mar 2022
|
Other versions |
|
Summary report(s) |
Stover et al JNT2014 Publication Phase IIa trial |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.